Motivational Interviewing for encouraging quit attempts among unmotivated smokers: study protocol of a randomized, controlled, efficacy trial

BMC Public Health

Robin Liston¹  Domonique Malomo¹  Andrea Bradley-Ewing¹  Edward Ellerbeck⁶  Ken Resnicow⁵  Christi Patten⁴  Karen Williams²  Kimber Richter⁶  Kathy Goggin¹  Kari Jo Harris³  Delwyn Catley¹ 

[1] Department of Psychology, University of Missouri-Kansas City, 5100 Rockhill Road, Kansas City, MO 64110, USA;Department of Biomedical and Health Informatics, University of Missouri – Kanas City School of Medicine, 2411 Holmes Street, Kansas City, MO 64108, USA;School of Public and Community Health Sciences, The University of Montana, 32 Campus Drive, Skaggs Rm 352, Missoula, MT 59812, USA;Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 5590, USA;Department of Health Behavior and Health Education, School of Public Health, University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109-2029, USA;Department of Preventive Medicine & Public Health, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 1008, 4004 Robinson, Kansas City, KS 66160, USA

关键词: Brief advice;    Health education;    Motivational Interviewing;    Smoking;   

Others  :  1163519
DOI  :  10.1186/1471-2458-12-456

 received in 2012-06-06, accepted in 2012-06-11,  发布年份 2012

【 摘 要 】

Background

Although the current Clinical Practice Guideline recommend Motivational Interviewing for use with smokers not ready to quit, the strength of evidence for its use is rated as not optimal. The purpose of the present study is to address key methodological limitations of previous studies by ensuring fidelity in the delivery of the Motivational Interviewing intervention, using an attention-matched control condition, and focusing on unmotivated smokers whom meta-analyses have indicated may benefit most from Motivational Interviewing. It is hypothesized that MI will be more effective at inducing quit attempts and smoking cessation at 6-month follow-up than brief advice to quit and an intensity-matched health education condition.

Methods/Design

A sample of adult community resident smokers (N = 255) who report low motivation and readiness to quit are being randomized using a 2:2:1 treatment allocation to Motivational Interviewing, Health Education, or Brief Advice. Over 6 months, participants in Motivational Interviewing and Health Education receive 4 individual counseling sessions and participants in Brief Advice receive one brief in-person individual session at baseline. Rigorous monitoring and independent verification of fidelity will assure the counseling approaches are distinct and delivered as planned. Participants complete surveys at baseline, week 12 and 6-month follow-up to assess demographics, smoking characteristics, and smoking outcomes. Participants who decide to quit are provided with a self-help guide to quitting, help with a quit plan, and free pharmacotherapy. The primary outcome is self-report of one or more quit attempts lasting at least 24 hours between randomization and 6-month follow-up. The secondary outcome is biochemically confirmed 7-day point prevalence cessation at 6-month follow-up. Hypothesized mediators of the presumed treatment effect on quit attempts are greater perceived autonomy support and autonomous motivation. Use of pharmacotherapy is a hypothesized mediator of Motivational Interviewing’s effect on cessation.

Discussion

This trial will provide the most rigorous evaluation to date of Motivational Interviewing’s efficacy for encouraging unmotivated smokers to make a quit attempt. It will also provide effect-size estimates of MI’s impact on smoking cessation to inform future clinical trials and inform the Clinical Practice Guideline.

Trial registration

ClinicalTrials.gov NCT01188018

【 授权许可】

   
2012 Catley et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Centers for Disease Control and Prevention: State-specific prevalence of cigarette smoking and smokeless tobacco use among adults –- United States, 2009. MMWR Morb Mortal Wkly Rep 2010, 59:1400-1406.
• [2]Centers for Disease Control and Prevention: Smoking-attributable mortality, years of potential life lost, and productivity losses–United States, 2000–2004. MMWR Morb Mortal Wkly Rep 2008, 57:1226-1228.
• [3]Pierce JP, Gilpin E: How long will today's new adolescent smoker be addicted to cigarettes? Am J Public Health 1996, 86:253-256.
• [4]Doll R, Peto R, Boreham J, Sutherland I: Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer 2005, 92:426-429.
• [5]Centers for Disease Control and Prevention: Cigarette smoking among adults-United States, 2000. MMWR Morb Mortal Wkly Rep 2002, 51:642-645.
• [6]Prochaska JO, DiClemente CC: Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983, 51:390-395.
• [7]Bailey L: An Overview of NAQC. In National Network of Tobacco Cessation Quitlines -- 2006 Regional Meeting. San Diego, CA: Western Region; 2006.
• [8]Association of American Medical Colleges: Physician behavior and practice patterns related to smoking cessation: Summay report. 2007.
• [9]Meredith LS, Yano EM, Hickey SC, Sherman SE: Primary care provider attitudes are associated with smoking cessation counseling and referral. Med Care 2005, 43:929-934.
• [10]Glasgow RE, Vogt TM, Boles SM: Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health 1999, 89:1322-1327.
• [11]Miller WR, Rollnick S: Ten things that Motivational Interviewing is not. Behav Cogn Psychother 2009, 37:129-140.
• [12]Lai DT, Cahill K, Qin Y, Tang JL: Motivational interviewing for smoking cessation. Cochrane Database Syst Rev 2011, CD006936.
• [13]Heckman CJ, Egleston BL, Hofmann MT: Efficacy of motivational interviewing for smoking cessation: a systematic review and meta-analysis. Tob Control 2010, 19:410-416.
• [14]Lundahl BW, Kunz C, Brownell C, Tollefson D, Burke BL: A Meta-Analysis of Motivational Interviewing: Twenty-Five Years of Empirical Studies. Res Social Work Prac 2010, 20:137-160.
• [15]Fiore MC, Jaen CR, Baker TB, et al.: Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: Department of Health and Human Services. Public Health Service; 2008.
• [16]Miller WR, Yahne CE, Moyers TB, Martinez J, Pirritano M: A randomized trial of methods to help clinicians learn Motivational Interviewing. J Consult Clin Psychol 2004, 72:1050-1062.
• [17]Hettema J, Steele J, Miller WR: Motivational Interviewing. Annu Rev Clin Psychol 2005, 1:91-111.
• [18]Ahluwalia JS, Okuyemi K, Nollen N, Choi WS, Kaur H, Pulvers K, Mayo MS: The effects of nicotine gum and counseling among African American light smokers: a 2 x 2 factorial design. Addiction 2006, 101:883-891.
• [19]Pearce MS, Hayes L: Self-reported smoking status and exhaled carbon monoxide: results from two population-based epidemiologic studies in the North of England. Chest 2005, 128:1233-1238.
• [20]Maclaren DJ, Conigrave KM, Robertson JA, Ivers RG, Eades S, Clough AR: Using breath carbon monoxide to validate self-reported tobacco smoking in remote Australian Indigenous communities. Popul Health Metr 2010, 8:2. BioMed Central Full Text
• [21]Miller WR, Rollnick S: Motivational Interviewing: Preparing people for change. 2nd edition. New York: Guilford Press; 2002.
• [22]Hettema JE, Hendricks PS: Motivational interviewing for smoking cessation: a meta-analytic review. J Consult Clin Psychol 2010, 78:868-884.
• [23]Eisenberg MJ, Filion KB, Yavin D, Belisle P, Mottillo S, Joseph L, Gervais A, O'Loughlin J, Paradis G, Rinfret S, Pilote L: Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. Cmaj 2008, 179:135-144.
• [24]Potts LA, Garwood CL: Varenicline: the newest agent for smoking cessation. Am J Health Syst Pharm 2007, 64:1381-1384.
• [25]Stack NM: Smoking cessation: an overview of treatment options with a focus on varenicline. Pharmacotherapy 2007, 27:1550-1557.
• [26]Moyers TB, Martin T, Manuel JK, Miller WR, Ernst D: Motivational Interviewing Treatment Integrity 3.1.1 (MITI 3.1.1). University of New Mexico Center on Alcoholism, Substance Abuse and Addictions (CASAA); 2010.
• [27]Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J: The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995, 90:607-614.
• [28]Richter KP, Gibson CA, Ahluwalia JS, Schmelzle KH: Tobacco use and quit attempts among methadone maintenance clients. Am J Public Health 2001, 91:296-299.
• [29]Ahluwalia JS, Harris KJ, Catley D, Okuyemi KS, Mayo MS: Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. JAMA 2002, 288:468-474.
• [30]Centers for Disease Control and Prevention: Cigarette smoking among adults–United States, 2006. MMWR Morb Mortal Wkly Rep 2007, 56:1157-1161.
• [31]Boardman T, Catley D, Mayo MS, Ahluwalia JS: Self-efficacy and motivation to quit during participation in a smoking cessation program. Int J Behav Med 2005, 12:266-272.
• [32]Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE: Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003, 5:13-25.
• [33]Benowitz NL: Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002, 4:149-159.
• [34]Cooke F, Bullen C, Whittaker R, McRobbie H, Chen MH, Walker N: Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status. Nicotine Tob Res 2008, 10:607-612.
• [35]Levesque CS, Williams GC, Elliot D, Pickering MA, Bodenhamer B, Finley PJ: Validating the theoretical structure of the Treatment Self-Regulation Questionnaire (TSRQ) across three different health behaviors. Health Educ Res 2007, 22:691-702.
• [36]Williams GC, Gagne M, Ryan RM, Deci EL: Facilitating autonomous motivation for smoking cessation. Health Psychol 2002, 21:40-50.
• [37]Williams GC, McGregor HA, Sharp D, Levesque C, Kouides RW, Ryan RM, Deci EL: Testing a self-determination theory intervention for motivating tobacco cessation: supporting autonomy and competence in a clinical trial. Health Psychol 2006, 25:91-101.
• [38]Baron RM, Kenny DA: The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986, 51:1173-1182.
• [39]MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V: A comparison of methods to test mediation and other intervening variable effects. Psychol Methods 2002, 7:83-104.
• [40]Sobel ME: Asymptotic confidence intervals for indirect effects in structural equation models. In Sociological Methodology. Edited by Leinhardt S. Washington DC: American Sociological Association; 1982:290-312.